Lynsey Corless

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

Zobair M. Younossi, Vlad Ratziu, Rohit Loomba et al. · The Lancet · 2019 · 1.2K citations · Full text

Interim Analysis, Metabolic Associated Steatohepatitis, Hepatology +7

Seladelpar (MBX-8025), a selective PPAR-δ agonist, in patients with primary biliary cholangitis with an inadequate response to ursodeoxycholic acid: a double-blind, randomised, placebo-controlled, phase 2, proof-of-concept study

David Jones, Pol Boudes, Mark G. Swain et al. · ˜The œLancet. Gastroenterology & hepatology · 2017 · 181 citations

Molecular Pharmacology, Selective Ppar-δ Agonist, Hepatology +11

Vps4 and the ESCRT-III complex are required for the release of infectious hepatitis C virus particles

Lynsey Corless, Colin M. Crump, Stephen Griffin et al. · Journal of General Virology · 2009 · 111 citations · Full text

Virus Structure, Viral Replication, Escrt Complexes +14

A Randomized, Controlled Trial of Vitamin D Supplementation on Cardiovascular Risk Factors, Hormones, and Liver Markers in Women with Polycystic Ovary Syndrome

Zeeshan Javed, Maria Papageorgiou, Harshal Deshmukh et al. · Nutrients · 2019 · 96 citations · Full text

Exercise intensity and the protection from postprandial vascular dysfunction in adolescents

Bert Bond, Phillip E. Gates, Sarah R. Jackman et al. · American Journal of Physiology-Heart and Circulatory Physiology · 2015 · 40 citations · Full text

Hypertension, Physical Activity, Adolescent Cardiovascular Health +19